Table 1.
Sociodemographic and clinical data of the patients
| CHD group (n = 46) |
CAPD group (n = 43) |
NHD group (n = 40) |
RT group (n = 36) |
p value | |
|---|---|---|---|---|---|
| Age, years | 34.6 ± 5.4 | 34.5 ± 5.8 | 35.2 ± 5.1 | 34.5 ± 4.8 | 0.21 |
| Primary kidney disease, s% | 1.0 | ||||
| Glomerulonephritis | 58.7 | 60.5 | 62.5 | 61.1 | |
| Pyelonephritis | 4.3 | 4.6 | 5.0 | 5.6 | |
| Hypertensive nephrosclerosis | 8.7 | 9.3 | 10.0 | 8.3 | |
| Diabetic nephropathy | 15.3 | 14.0 | 12.5 | 13.9 | |
| Polycystic kidney disease | 8.7 | 4.6 | 2.5 | 5.5 | |
| Lupus nephritis | 4.3 | 4.6 | 7.5 | 2.8 | |
| Other | 0 | 2.4 | 0 | 2.8 | |
| Duration of renal disease, years | 4.7 ± 1.3 | 4.5 ± 1.5 | 4.8 ± 2.2 | 4.7 ± 1.6 | 0.17 |
| Body mass index | 23.5 ± 7.5 | 23.7 ± 6.3 | 24.1 ± 4.9 | 23.8 ± 5.2 | 0.63 |
| Hemoglobin, g/l | 11.7 ± 2.8 | 12.1 ± 8.9 | 12.5 ± 4.5 | 11.6 ± 2.4 | 0.11 |
| rHuEPO, IU/week | 8,417.2 ± 1,133.8 | 8,222.5 ± 948.1 | 8,208.9 ± 1,247.1 | 8,112.0 ± 1,344.9 | 0.53 |
| Type of medications for kidney disease, s% | |||||
| Glucocorticoids | 69.6 | 72.1 | 77.5 | 75.0 | 0.86 |
| Immunosuppressants | 41.3 | 41.9 | 45.0 | 44.4 | 0.98 |
| Tripterygium glycosides | 17.4 | 16.3 | 17.5 | 19.4 | 0.99 |
| Number of medications for kidney disease1, s% | 0.98 | ||||
| <2 medications | 28.3 | 27.9 | 25.0 | 25.0 | |
| >2 medications | 71.7 | 72.1 | 75.0 | 75.0 | |
| Duration of medication use for kidney disease1, s% | 0.99 | ||||
| <2 years | 6.5 | 7.0 | 7.5 | 8.3 | |
| ≥2 years | 93.5 | 93.0 | 92.5 | 91.7 | |
| Dialysis duration, months | 52.2 ± 7.8 | 48.5 ± 11.3 | 51.9 ± 10.1 | 49.8 ± 10.2 | 0.49 |
| Dialysis sessions, n/week | 3.2 ± 0.3 | 5.5 ± 0.5 | 0.03 | ||
| Duration of dialysis sessions, h | 4.3 ± 0.2 | 7.4 ± 1.6 | 0.02 | ||
| Total dialysis time, h/week | 11.1 ± 1.9 | 35.3 ± 4.7 | 0.003 | ||
| Weight after dialysis, kg | 67.7 ± 8.3 | 66.9 ± 10.1 | 65.6 ± 5.2 | 0.42 | |
| Residual kidney function, s% | |||||
| <100 ml/24 h | 87.0 | 67.4 | 77.5 | 0 | 0.001 |
| ≥100 ml/24 h | 13.0 | 32.6 | 22.5 | 100 | |
| Weekly Kt/V | 3.24 ± 1.26 | 2.95 ± 1.25 | 4.27 ± 0.83 | 0.04 | |
1
Medications associated with ovarian function include glucocorticoids, immunosuppressants and tripterygium glycosides.